Cabaletta Net Borrowings vs End Period Cash Flow Analysis

CABA Stock

USD 2.42 0.13 5.68%

Cabaletta Bio financial indicator trend analysis is way more than just evaluating Cabaletta Bio prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cabaletta Bio is a good investment. Please check the relationship between Cabaletta Bio Net Borrowings and its End Period Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.

Net Borrowings vs End Period Cash Flow

Net Borrowings vs End Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cabaletta Bio Net Borrowings account and End Period Cash Flow. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Cabaletta Bio's Net Borrowings and End Period Cash Flow is -0.48. Overlapping area represents the amount of variation of Net Borrowings that can explain the historical movement of End Period Cash Flow in the same time period over historical financial statements of Cabaletta Bio, assuming nothing else is changed. The correlation between historical values of Cabaletta Bio's Net Borrowings and End Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Borrowings of Cabaletta Bio are associated (or correlated) with its End Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when End Period Cash Flow has no effect on the direction of Net Borrowings i.e., Cabaletta Bio's Net Borrowings and End Period Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.48

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Net Borrowings

The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.

End Period Cash Flow

Most indicators from Cabaletta Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cabaletta Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.The current year's Issuance Of Capital Stock is expected to grow to about 194.5 M, whereas Selling General Administrative is forecasted to decline to about 10.9 M.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	46.3M	54.1M	74.7M	78.4M
Research Development	32.5M	39.3M	55.4M	58.2M

Total Operating Expenses Research Development

Cabaletta Bio fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Other Stockholder Equity	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Other Assets	Other Current Assets	Deferred Long Term Liab	Property Plant And Equipment Net	Property Plant And Equipment Gross	Property Plant Equipment	Retained Earnings Total Equity	Short Term Investments
Total Assets		0.81	0.96	0.99	0.84	-0.98	-0.93	0.95	0.92	1.0	0.73	-0.05	0.95	0.93	0.32	0.99	1.0	1.0	-0.29	0.83	-0.78	0.69	0.83	0.72	-0.76	0.81
Other Current Liab	0.81		0.78	0.81	0.89	-0.86	-0.77	0.76	0.89	0.81	0.59	-0.1	0.9	0.77	0.22	0.81	0.81	0.81	-0.01	0.7	-0.37	0.5	0.55	0.62	-0.77	0.39
Total Current Liabilities	0.96	0.78		0.95	0.74	-0.9	-0.99	1.0	0.83	0.95	0.79	-0.09	0.94	1.0	0.3	0.95	0.95	0.94	-0.15	0.68	-0.81	0.8	0.93	0.83	-0.88	0.87
Total Stockholder Equity	0.99	0.81	0.95		0.86	-0.98	-0.92	0.94	0.91	0.99	0.77	-0.17	0.95	0.93	0.2	1.0	0.99	0.99	-0.3	0.85	-0.77	0.68	0.82	0.71	-0.75	0.79
Net Tangible Assets	0.84	0.89	0.74	0.86		-0.9	-0.74	0.71	0.94	0.84	0.63	-0.2	0.91	0.71	0.12	0.86	0.84	0.85	-0.03	0.91	-0.34	0.55	0.56	0.61	-0.66	0.43
Net Debt	-0.98	-0.86	-0.9	-0.98	-0.9		0.87	-0.9	-0.96	-0.98	-0.68	0.03	-0.94	-0.87	-0.32	-0.98	-0.99	-0.99	0.29	-0.89	0.68	-0.61	-0.73	-0.66	0.72	-0.69
Retained Earnings	-0.93	-0.77	-0.99	-0.92	-0.74	0.87		-0.99	-0.81	-0.93	-0.81	0.08	-0.94	-0.99	-0.32	-0.92	-0.92	-0.92	0.06	-0.66	0.76	-0.87	-0.95	-0.88	0.9	-0.87
Accounts Payable	0.95	0.76	1.0	0.94	0.71	-0.9	-0.99		0.81	0.95	0.78	-0.05	0.92	0.99	0.34	0.94	0.95	0.94	-0.17	0.67	-0.83	0.79	0.93	0.82	-0.87	0.88
Cash	0.92	0.89	0.83	0.91	0.94	-0.96	-0.81	0.81		0.92	0.71	-0.02	0.91	0.8	0.33	0.91	0.92	0.93	-0.2	0.9	-0.48	0.62	0.64	0.7	-0.68	0.58
Cash And Short Term Investments	1.0	0.81	0.95	0.99	0.84	-0.98	-0.93	0.95	0.92		0.73	-0.05	0.94	0.93	0.32	0.99	1.0	1.0	-0.3	0.84	-0.78	0.68	0.82	0.71	-0.76	0.8
Common Stock Shares Outstanding	0.73	0.59	0.79	0.77	0.63	-0.68	-0.81	0.78	0.71	0.73		-0.45	0.73	0.8	-0.06	0.77	0.72	0.71	-0.12	0.6	-0.55	0.83	0.79	0.87	-0.7	0.76
Non Current Liabilities Total	-0.05	-0.1	-0.09	-0.17	-0.2	0.03	0.08	-0.05	-0.02	-0.05	-0.45		-0.14	-0.12	0.91	-0.17	-0.05	-0.05	0.04	-0.14	0.08	-0.08	-0.09	-0.08	0.09	-0.08
Capital Surpluse	0.95	0.9	0.94	0.95	0.91	-0.94	-0.94	0.92	0.91	0.94	0.73	-0.14		0.93	0.24	0.95	0.94	0.94	-0.01	0.8	-0.62	0.74	0.82	0.78	-0.88	0.69
Other Stockholder Equity	0.93	0.77	1.0	0.93	0.71	-0.87	-0.99	0.99	0.8	0.93	0.8	-0.12	0.93		0.28	0.93	0.93	0.92	-0.16	0.62	-0.81	0.8	0.93	0.83	-0.87	0.87
Total Liab	0.32	0.22	0.3	0.2	0.12	-0.32	-0.32	0.34	0.33	0.32	-0.06	0.91	0.24	0.28		0.2	0.32	0.32	0.02	0.14	-0.19	0.3	0.29	0.31	-0.27	0.26
Net Invested Capital	0.99	0.81	0.95	1.0	0.86	-0.98	-0.92	0.94	0.91	0.99	0.77	-0.17	0.95	0.93	0.2		0.99	0.99	-0.3	0.85	-0.77	0.68	0.82	0.71	-0.75	0.79
Total Current Assets	1.0	0.81	0.95	0.99	0.84	-0.99	-0.92	0.95	0.92	1.0	0.72	-0.05	0.94	0.93	0.32	0.99		1.0	-0.3	0.84	-0.77	0.68	0.82	0.71	-0.75	0.8
Net Working Capital	1.0	0.81	0.94	0.99	0.85	-0.99	-0.92	0.94	0.93	1.0	0.71	-0.05	0.94	0.92	0.32	0.99	1.0		-0.31	0.85	-0.77	0.67	0.81	0.7	-0.74	0.79
Other Assets	-0.29	-0.01	-0.15	-0.3	-0.03	0.29	0.06	-0.17	-0.2	-0.3	-0.12	0.04	-0.01	-0.16	0.02	-0.3	-0.3	-0.31		-0.17	0.47	0.21	0.01	0.2	-0.31	-0.3
Other Current Assets	0.83	0.7	0.68	0.85	0.91	-0.89	-0.66	0.67	0.9	0.84	0.6	-0.14	0.8	0.62	0.14	0.85	0.84	0.85	-0.17		-0.43	0.5	0.54	0.53	-0.53	0.5
Deferred Long Term Liab	-0.78	-0.37	-0.81	-0.77	-0.34	0.68	0.76	-0.83	-0.48	-0.78	-0.55	0.08	-0.62	-0.81	-0.19	-0.77	-0.77	-0.77	0.47	-0.43		-0.51	-0.79	-0.47	0.56	-0.9
Property Plant And Equipment Net	0.69	0.5	0.8	0.68	0.55	-0.61	-0.87	0.79	0.62	0.68	0.83	-0.08	0.74	0.8	0.3	0.68	0.68	0.67	0.21	0.5	-0.51		0.92	0.98	-0.8	0.81
Property Plant And Equipment Gross	0.83	0.55	0.93	0.82	0.56	-0.73	-0.95	0.93	0.64	0.82	0.79	-0.09	0.82	0.93	0.29	0.82	0.82	0.81	0.01	0.54	-0.79	0.92		0.89	-0.85	0.94
Property Plant Equipment	0.72	0.62	0.83	0.71	0.61	-0.66	-0.88	0.82	0.7	0.71	0.87	-0.08	0.78	0.83	0.31	0.71	0.71	0.7	0.2	0.53	-0.47	0.98	0.89		-0.84	0.76
Retained Earnings Total Equity	-0.76	-0.77	-0.88	-0.75	-0.66	0.72	0.9	-0.87	-0.68	-0.76	-0.7	0.09	-0.88	-0.87	-0.27	-0.75	-0.75	-0.74	-0.31	-0.53	0.56	-0.8	-0.85	-0.84		-0.65
Short Term Investments	0.81	0.39	0.87	0.79	0.43	-0.69	-0.87	0.88	0.58	0.8	0.76	-0.08	0.69	0.87	0.26	0.79	0.8	0.79	-0.3	0.5	-0.9	0.81	0.94	0.76	-0.65

Click cells to compare fundamentals

Cabaletta Bio Account Relationship Matchups

Cabaletta Bio fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	141.5M	114.7M	126.3M	117.0M	253.7M	266.3M
Other Current Liab	2.2M	3.9M	6.0M	2.7M	4.3M	3.1M
Total Current Liabilities	3.1M	5.2M	8.4M	9.5M	16.0M	16.8M
Total Stockholder Equity	138.3M	109.5M	118.0M	104.5M	236.2M	248.0M
Net Tangible Assets	138.3M	109.5M	116.6M	104.5M	120.2M	84.0M
Net Debt	(136.2M)	(101.4M)	(122.2M)	(76.5M)	(188.2M)	(178.8M)
Retained Earnings	(33.0M)	(66.3M)	(112.6M)	(165.6M)	(233.2M)	(221.6M)
Accounts Payable	920K	1.2M	2.3M	2.5M	4.5M	4.8M
Cash	136.2M	101.4M	122.2M	81.6M	193.2M	104.9M
Non Current Assets Total	916K	1.2M	1.8M	8.1M	9.2M	9.6M
Non Currrent Assets Other	101K	299K	357K	565K	1.7M	1.8M
Cash And Short Term Investments	136.2M	108.7M	122.2M	106.5M	241.2M	253.3M
Common Stock Shares Outstanding	24.0M	23.1M	25.7M	29.3M	40.9M	28.3M
Liabilities And Stockholders Equity	141.5M	114.7M	126.3M	117.0M	253.7M	266.3M
Non Current Liabilities Total	920K	1.2M	2.3M	3.0M	1.5M	1.4M
Capital Surpluse	1.8M	171.3M	175.8M	270.1M	310.6M	326.2M
Other Stockholder Equity	29.8M	175.8M	230.5M	270.1M	469.4M	492.9M
Total Liab	3.1M	5.2M	8.4M	12.4M	17.5M	10.5M
Net Invested Capital	138.3M	109.5M	118.0M	104.5M	236.2M	248.0M
Total Current Assets	140.6M	113.5M	124.5M	108.8M	244.5M	256.7M
Net Working Capital	137.4M	108.4M	116.2M	99.3M	228.5M	239.9M
Other Assets	101K	299.0	357K	565K	1.0	0.95
Other Current Assets	4.3M	1.9M	2.3M	2.3M	3.2M	2.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Cabaletta Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cabaletta Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cabaletta Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cabaletta Bio Stock:

How To Invest In Cabaletta

Details

Is Cabaletta Stock a good investment?

Details

What is Cabaletta Bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.

You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.16)

Return On Assets

(0.31)

Return On Equity

(0.48)

The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabaletta Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cabaletta Net Borrowings vs End Period Cash Flow Analysis

Net Borrowings vs End Period Cash Flow

Net Borrowings vs End Period Cash Flow Correlation Analysis

Correlation Coefficient

Net Borrowings

End Period Cash Flow

Cabaletta Bio fundamental ratios Correlations

Cabaletta Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cabaletta Bio fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets
Accounts Payable	+ 1.0	Total Current Liabilities
Other Stockholder Equity	+ 1.0	Total Current Liabilities
Net Invested Capital	+ 1.0	Total Stockholder Equity

Other Stockholder Equity	- 0.99	Retained Earnings
Accounts Payable	- 0.99	Retained Earnings
Net Working Capital	- 0.99	Net Debt
Total Current Assets	- 0.99	Net Debt
Retained Earnings	- 0.99	Total Current Liabilities
Net Invested Capital	- 0.98	Net Debt